Review Article

Autophagy-Associated lncRNAs: Promising Targets for Neurological Disease Diagnosis and Therapy

Table 1

lncRNAs associated with autophagy regulation in neurological diseases.

Neurological diseaseslncRNAMain target geneExpressionMechanismFunctionModelsRef.

Alzheimer’s disease17AGABABR2Up17A downregulation promotes autophagy by elevating GABABR2 expressionInducing Aβ secretion and increment of the Aβ42/40 ratioSH-SY5Y cells treated with amyloid β peptide1-42[41, 42]
NEAT1NEDD4L and PINK1UpInhibiting PINK1-independent mitophagy by promoting NEDD4L-mediated PINK1 ubiquitination and degradationIncreasing Aβ accumulationAPP/PS1 mice[46]
Parkinson’s diseaseNEAT1PINK1UpPromoting autophagy through stabilizing PINK1 proteinAlleviating dopaminergic neuronal injuryMPTP mouse model and MPP+-induced SH-SY5Y[51]
SNHG1miR-221/222UpSNHG1 downregulation increased LC3-II levels through the miR-221/222/p27/mTOR pathwayEnhancing α-synuclein aggregation thus leads to dopaminergic toxicityMPTP mouse model and MPP+-induced MN9D cells[56]
HOTAIRLRRK2UpPromoting autophagy by improving LRRK2 mRNA stability and activating ERK/MAPK pathwaysIncreasing the loss of striatal dopamine and promoting PD progressionMPTP mouse model and MPP+-induced SH-SY5Y[57]
miR-126-5pSuppressing autophagy trough HOTAIR/miR-126-5p/RAB3IP axisElevating the loss of striatal dopamine and the accumulation of α-synucleinMPTP rat model and MPP+-induced SH-SY5Y[59]
HAGLROSmiR-100UpInhibiting autophagy via regulating miR-100/ATG10 axis and PI3K/AKT/mTOR pathway activationContributing to the development of PDMPTP mouse model and MPP+-induced SH-SY5Y[61]
Ischemic strokeH19DUSP5UpPromoting autophagy through regulating DUSP5-ERK1/2 axisAggravating cerebral ischemia-reperfusion injurySH-SY5Y cell culture[71]
SNHG12UnknownUpActivating beclin1-dependent autophagyAlleviating cerebral ischemia-reperfusion injurySH-SY5Y cell culture[76]
MALAT1miR-26bUpActivating autophagy through upregulation of ULK2Attenuating ischemia-reperfusion injuryBMEC culture[74]
miR-200c-3pPromoting autophagy by regulating miR-200c-3p/Sirt1 axis[75]
miR-30aPromoting autophagy via MALAT1/miR-30a/beclin1 axisAggravating ischemic injuryMouse brain and N2a cells[73]
KCNQ1OT1miR-200aUpPromoting the formation of autophagosomes through the mir-200a/FOXO3/ATG7 axisAggravating neurological impairmentsMouse brain and SH-SY5Y cell culture[78]
EpilepsyMALAT1PI3K/AKTUpActivating autophagy by inhibiting PI3K/AKT signaling pathwayPromoting the degeneration and necrosis of hippocampal neuronsRats with EP[81]
GliomaMEG3PI3K/AKT/mTORDownActivating autophagy by downregulating of the PI3K/AKT/mTOR pathways and the upregulating of Sirt7Repressing cell proliferation and migrationU251 cell lines[92]
UnknownSuppressing cisplatin-induced excessive autophagyIncreasing glioma cell sensitive to cisplatinU87 cell lines[93]
PVT1miR-186UpActivating autophagy through upregulation of ATG7 and Beclin1Promoting proliferation, migration and angiogenesishCMEC/D3[94]
MALAT1miR-101UpActivating autophagy through upregulationPromoting cell proliferationGlioma tissue from patients, U87, U118,[96]
STMN1, RAB5A, and ATG4DU251, U373, and D247 cell lines
miR-384Activating autophagy through upregulation GOLM1Enhancing glioma migration and invasionGlioma tissue from patients, SHG-44, and LN229 cells[100]
GAS5mTORUpSuppressing cisplatin-induced excessive autophagy in an mTOR-independent mannerIncreasing glioma cell sensitive to cisplatinU87 and u138 cell lines[103]